Navigation Links
CRO Solutions, Inc. Announces Opening of New Division - VxP Pharma Services, Inc.
Date:7/22/2013

INDIANAPOLIS, July 22, 2013 /PRNewswire/ -- CRO Solutions, Inc. announced the launch of VxP Pharma, Inc.- a wholly owned subsidiary of CRO Solutions, Inc. VxP Pharma is comprised of the combined services of the independently owned and operated "niche" CROs of parent company - CRO Solutions, Inc. VxP Pharma will offer pharmaceutical development services, as well as technical support, for the development and production of pharmaceuticals, diagnostics, and drug/device combination products from Discovery through Phase IIb.

The majority of VxP Pharma's Labs are located in the United States, although VxP also has facilities in Europe and Asia. All VxP sites have been fully audited by CRO Solutions/VxP Pharma, as well as by global pharmaceutical and biotechnology clients. Most sites have also been audited by the US FDA as well as other international regulatory agencies.

VxP Pharma CEO - Raymond E Peck says "Pharmaceutical and biotech research scientists throughout the industry tell us that they prefer to work with smaller, focused, Contract Research Organizations (CROs), rather than with the huge multinational 'one-size-fits-all' CROs. For these people, VxP Pharma is a perfect fit because we offer a single point of contact, as well as the confidence that, if you work with VxP, you are working with a state-of-the-art lab that has been subject to a complete audit, including, in most cases, an audit by the US FDA. Because VxP consists of smaller, independently owned and operated facilities who focus on only one area of drug development, our drug development clients get all the advantages of working directly with a specialist "niche" CRO, including being able to work with some of the best subject matter experts in the industry."

VxP Pharma will operate as a full service CRO offering drug development services from Discovery through Phase llb. VxP is headquartered in Indianapolis, Indiana. To find out more, please visit: www.vxppharma.com or call at 317-759-2299.

Press Release Contact Information:
Lisa Fay
Director of Client Development
VxP Pharma Services, Inc.
317-759-2299
Lisa.Fay@VxPPharma.com

This release was issued through WebWire(R). For more information visit http://www.webwire.com.


'/>"/>
SOURCE VxP Pharma Services, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. MEDIFIRST SOLUTIONS, INC. To Exhibit At The Orlando International Beauty Show
2. Medifirst Solutions, Inc. Announces Update To Shareholders
3. Medifirst Solutions, Inc. Announces New Healthcare And Wellness Division
4. Comprehensive Care Corporation Names Colonel Ramon Martinez President of CompCare Pharmacy Solutions, Inc.
5. Care Corporation Names Colonel Ramon Martinez President of CompCare Pharmacy Solutions, Inc.
6. inVentiv Health Forms Strategic Alliance With Bell Medical Solutions, One Of Japans Top Clinical Research Organizations
7. Managed Health Care Associates, Inc. (MHA) Announced Erik Halstrom, Vice President of MHA Specialty Pharmacy Solutions, Will Serve on the National Association of Specialty Pharmacy (NASP) Board of Directors
8. Qualyst Transporter Solutions, LLC Announces New Alliance with GenoMembrane
9. Cardinal Health Specialty Solutions, Health Alliance Plan Work With Michigan Oncologists to Improve Quality, Curb Costs of Cancer Care
10. Catalent Pharma Solutions, Inc. Announces Increase In Tender Cap For Its Cash Tender Offer For Its 9-1/2%/10-1/4% Senior PIK-Election Notes Due 2015
11. Catalent Pharma Solutions, Inc. Announces Cash Tender Offer for up to $250 Million of Its 9-1/2%/10-1/4% Senior PIK-Election Notes due 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... 2016 Een app die artsen ... collectief patiënten kunnen behandelen, hun kennis kunnen delen en ... de nieuwe en revolutionaire MDLinking App, ontwikkeld door een ... dr. Hans Flu en oncologisch chirurg dr. Gijs ... is, wordt op dinsdag 24 mei officieel gepresenteerd op ...
(Date:5/23/2016)... 2016 Transparency Market Research has ... Insufficiency Market - Global Industry Analysis, Size, Share, Growth, ... the report, the exocrine pancreatic insufficiency market is anticipated ... to 2023 to reach US$2.85 Bn by 2023. ... by the deficiency of the exocrine pancreatic enzymes, causing ...
(Date:5/23/2016)... May 23, 2016 Non-invasive diagnostic ... of multiple diseases; ,Technology to be presented at Yissum’s ... Yissum Research Development Company of the Hebrew University of ... research agreement with Aurum Ventures MKI, the technology investment arm ... a new diagnostic approach for early detection of multiple ...
Breaking Medicine Technology:
(Date:5/24/2016)... ... May 24, 2016 , ... ... anticipated, web-based software module. The cutting-edge feature provides end users with an ... Izenda’s self-service business intelligence solution and its analytics engine. , This ...
(Date:5/24/2016)... ... May 24, 2016 , ... Celebration is in the Air, ... its 5th Annual Photo Contest. The label contest is underway, and hundreds of ... include a GoPro Hero4, a 40-inch high-definition flat-screen television, an Apple iPad Air ...
(Date:5/23/2016)... ... 23, 2016 , ... On Sunday, May 15, Rockynol Retirement ... assisted living center. After 18 months of construction, the new state-of-the-art structure was ... provides the latest in assisted living amenities and services, offering six different studio ...
(Date:5/23/2016)... ... ... Edward D. Buckingham, M.D . is excited announce that he has been ... out by the National Consumer Advisory Board to honor excellence in medicine. Only doctors ... award. , The National Consumer Advisory Board (NCAB) is a private organization created to ...
(Date:5/23/2016)... Angeles, CA (PRWEB) , ... May 23, 2016 , ... ... surgeons have noted that, less than 1% of United Kingdom residents who could benefit ... UK’s National Health Service (NHS) increases the number of bariatric procedures it offers to ...
Breaking Medicine News(10 mins):